glp-1 afib Glucagon-like peptide-1 receptor agonists and the risk of atrial fibrillation in adults with diabetes: a real-world study | Journal of General Internal Medicine GLP-1 Drugs May Have Role

The STEP-8 RCT found greater weight loss with semaglutide than with liraglutide at 68 weeks (Table 3).74 Comparisons of tirzepatide to semaglutide head-to-head remain limited to few studies.169,191,192 However, both the randomized clinical trial of Frias et al from 2021169 and the Bayesian meta-analysis of Ding et al from 2024191 did not evaluate the maximum dose of semaglutide, but rather the 1 mg weekly dosing

Michelle M

Potential Concerns and Barriers In addition to their side effects, there are several other potential issues of note regarding the use of GLP-1 drugs like Ozempic for mental health treatment

(B) The spleen size is basically normal

GLP-1 agonists are a class of medications designed to mimic the action of a natural hormone called glucagon-like peptide 1

That exemption framework is built on an assumption: that compounding pharmacies are operating with adequate quality controls